- Home
- ALTG vs CTNM Comparison
ALTG vs CTNM Comparison
Compare ALTG & CTNM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ALTG
- CTNM
- Stock Information
- Founded
- ALTG 1984
- CTNM 2009
- Country
- ALTG United States
- CTNM United States
- Employees
- ALTG N/A
- CTNM N/A
- Industry
- ALTG Industrial Machinery/Components
- CTNM
- Sector
- ALTG Industrials
- CTNM
- Exchange
- ALTG Nasdaq
- CTNM Nasdaq
- Market Cap
- ALTG 119.3M
- CTNM 114.1M
- IPO Year
- ALTG N/A
- CTNM 2024
- Fundamental
- Price
- ALTG $4.75
- CTNM $3.66
- Analyst Decision
- ALTG Buy
- CTNM Strong Buy
- Analyst Count
- ALTG 3
- CTNM 4
- Target Price
- ALTG $11.67
- CTNM $22.50
- AVG Volume (30 Days)
- ALTG 162.3K
- CTNM 102.0K
- Earning Date
- ALTG 05-07-2025
- CTNM 05-14-2025
- Dividend Yield
- ALTG 4.80%
- CTNM N/A
- EPS Growth
- ALTG N/A
- CTNM N/A
- EPS
- ALTG N/A
- CTNM N/A
- Revenue
- ALTG $1,858,000,000.00
- CTNM N/A
- Revenue This Year
- ALTG $2.05
- CTNM N/A
- Revenue Next Year
- ALTG $3.24
- CTNM N/A
- P/E Ratio
- ALTG N/A
- CTNM N/A
- Revenue Growth
- ALTG N/A
- CTNM N/A
- 52 Week Low
- ALTG $3.54
- CTNM $3.35
- 52 Week High
- ALTG $11.39
- CTNM $22.00
- Technical
- Relative Strength Index (RSI)
- ALTG 47.44
- CTNM N/A
- Support Level
- ALTG $4.74
- CTNM N/A
- Resistance Level
- ALTG $5.12
- CTNM N/A
- Average True Range (ATR)
- ALTG 0.27
- CTNM 0.00
- MACD
- ALTG -0.04
- CTNM 0.00
- Stochastic Oscillator
- ALTG 2.15
- CTNM 0.00
About ALTG Alta Equipment Group Inc.
Alta Equipment Group Inc is an integrated equipment dealership platform in the U.S. Its segments are Material Handling and Construction Equipment. The Material Handling segment is engaged in operations related to the sale, service, and rental of lift trucks in Michigan, Illinois, Indiana, New York, Virginia, and throughout the New England states whereas, the Construction Equipment segment is principally engaged in operations related to the sale, service, and rental of construction equipment in Michigan, Indiana, Illinois, Ohio, New York, Florida and throughout the New England States.
About CTNM Contineum Therapeutics Inc. Class A Common Stock
Contineum Therapeutics Inc is a clinical stage biopharmaceutical company focused on discovering and developing novel, oral small molecule therapies for NI&I indications with high unmet need. Its internally-discovered drug candidates, PIPE-791 and PIPE-307, PIPE-791, is a novel, brain penetrant, small molecule inhibitor of the LPA1R in development for IPF and PIPE-307, is a novel, small molecule selective inhibitor of the muscarinic type 1 M1R, in development for depression and RRMS.